School of Traditional Chinese Medicine of Jinan University, Guangzhou, China.
Medicine (Baltimore). 2022 Dec 9;101(49):e32133. doi: 10.1097/MD.0000000000032133.
Taohong Siwu Decoction (THSWD) is a classic prescription of traditional Chinese medicine. Recent research has shown that the practical components of THSWD have specific curative effects on various cardiovascular diseases, including hypertension, suggesting THSWD could effectively lower blood pressure (BP) with fewer side effects. However, little information is available regarding the effectiveness of THSWD combined with antihypertensive medicine on hypertension.
This meta-analysis aimed to study the efficacy and safety of THSWD in treating hypertension.
According to the search strategy, 8 databases were searched, including China Knowledge Network (CNKI), Wanfang Database, VIP Database, Pubmed, China Biomedical Literature Database (CBM), web of science, EMBASE and Cochrane Library, for the randomized controlled trial of THSWD on hypertension. 9 RCTs were included and 827 patients were involved. This meta-analysis used RevMan 5.4 to evaluate the articles.
This review included 9 RCTs. All studies were THSWD with the antihypertensive drug compared with single antihypertensive western medicine. The total effective rate of THSWD combined with corresponding western medicine was significantly improved (Relative risk = 1.26; 95% CI: 1.16-1.37, P < .00001), which could effectively reduce the systolic BP (MD = -15.28 mm Hg; 95% CI: -20.17 to -10.40, P < .00001=, diastolic BP (MD = -9.70 mm Hg; 95% CI: -12.66 to -6.73, P < .00001), Triglycerides (MD = -1.48, 95%CI: -2.09 to -0.87, P < .00001), total cholesterol (MD = -1.43, 95% CI: -1.63 to -1.24, P < .00001) and low density lipoprotein cholesterol (MD = -0.93, 95% CI: -1.07 to -0.80, P < .00001). Compared with the single routine western medicine group, THSWD combined with the corresponding western medicine increased serum high-density lipoprotein (MD = 0.41, 95% CI: 0.35 to 0.46, P < .00001).
THSWD combined with antihypertensive drugs in treating hypertension was curative in lowering BP, improving blood lipid levels and reducing the incidence of adverse reactions compared to antihypertensive medications treatment. However, more high-quality studies are needed due to the biased results and the small number of studies for further verification of the effectiveness of THSWD, and providing a new treatment for clinical reference.
桃红四物汤(THSWD)是一种经典的中药方剂。最近的研究表明,THSWD 的实际成分对各种心血管疾病,包括高血压,具有特定的疗效,这表明 THSWD 可以有效地降低血压(BP),且副作用较少。然而,关于 THSWD 与降压药联合治疗高血压的疗效信息很少。
本荟萃分析旨在研究 THSWD 治疗高血压的疗效和安全性。
根据搜索策略,检索了 8 个数据库,包括中国知网(CNKI)、万方数据库、维普数据库、PubMed、中国生物医学文献数据库(CBM)、Web of Science、EMBASE 和 Cochrane 图书馆,以获取关于 THSWD 治疗高血压的随机对照试验。共纳入 9 项 RCT,涉及 827 例患者。本荟萃分析使用 RevMan 5.4 对文章进行评估。
本综述纳入了 9 项 RCT。所有研究均为 THSWD 联合降压西药与单纯降压西药的比较。THSWD 联合相应西药的总有效率明显提高(相对风险=1.26;95%CI:1.16-1.37,P<0.00001),可有效降低收缩压(MD=-15.28mmHg;95%CI:-20.17 至-10.40,P<0.00001)、舒张压(MD=-9.70mmHg;95%CI:-12.66 至-6.73,P<0.00001)、三酰甘油(MD=-1.48;95%CI:-2.09 至-0.87,P<0.00001)、总胆固醇(MD=-1.43;95%CI:-1.63 至-1.24,P<0.00001)和低密度脂蛋白胆固醇(MD=-0.93;95%CI:-1.07 至-0.80,P<0.00001)。与单纯常规西药组相比,THSWD 联合相应西药可提高血清高密度脂蛋白(MD=0.41;95%CI:0.35 至 0.46,P<0.00001)。
与降压药物治疗相比,THSWD 联合降压药物治疗高血压在降低血压、改善血脂水平和降低不良反应发生率方面具有疗效。然而,由于结果存在偏倚,且研究数量较少,需要更多高质量的研究进一步验证 THSWD 的有效性,为临床提供新的治疗参考。